Ghulam Rehman Mohyuddin, MD

Article

Nivolumab Use for First-Line Management of Hepatocellular Carcinoma: Results of a Real-World Cohort of Patients

Author:: Ghulam Rehman Mohyuddin, MD

Publish date: November 3, 2020

Several clinical trials have shown tolerability and efficacy of nivolumab to manage hepatocellular carcinoma; however, the outcomes in this retrosp...